Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 147
Filter
1.
Article in English | MEDLINE | ID: mdl-28237082

ABSTRACT

Arachidonic acid increased intracellular calcium, in cells expressing green fluorescent protein-tagged human FFA4 receptors, with an EC50 of ~40µM. This action was not blocked by cyclooxygenase or lipoxigenase inhibitors but it was inhibited by AH7614, a FFA4 antagonist. Arachidonic acid induced ERK activation accompanied by EGF receptor transactivation. However, EGF transactivation was not the major mechanism through which the fatty acid induced ERK phosphorylation, as evidenced by the inability of AG1478 to block it. Arachidonic acid increased FFA4 receptor phosphorylation that reached its maximum within 15min with an EC50 of ~30µM; inhibitors of protein kinase C partially diminish this effect and AH7614 blocked it. Arachidonic acid induced rapid and sustained Akt/PKB phosphorylation and FFA4 - ß-arrestin interaction. Confocal microscopy evidenced that FFA4 receptor activation and phosphorylation were associated to internalization. In conclusion, arachidonic acid is a bona fide FFA4 receptor agonist.


Subject(s)
Arachidonic Acid/pharmacology , ErbB Receptors/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Receptors, G-Protein-Coupled/metabolism , Calcium/metabolism , Cell Line , HEK293 Cells , Humans , Phosphorylation , Quinazolines/pharmacology , Signal Transduction/drug effects , Tyrphostins/pharmacology , beta-Arrestins/metabolism
2.
Oncogene ; 31(13): 1733-42, 2012 Mar 29.
Article in English | MEDLINE | ID: mdl-21841819

ABSTRACT

Inflammatory bowel disease (IBD) is an important etiologic factor in the development of colorectal cancer. However, the mechanism underlying carcinogenesis through chronic inflammation is still unknown. Activation-induced cytidine deaminase (AID) is induced by the inflammation and involved in various human carcinogenesis via its mutagenic activity. In the current study, we investigated whether the inflammation/AID axis plays an integral role in the development of colitis-associated cancers. Inflammation in the cecum was more severe than that in other colonic regions, and endogenous AID expression was enhanced most prominently in the inflamed cecal mucosa of interleukin (IL)-10(-/-) mice. Blockade of tumor necrosis factor (TNF)-α and IL-12 significantly suppressed AID expression. Although proinflammatory cytokine expression was comparable between IL-10(-/-)AID(+/+) and IL-10(-/-)AID(-/-) mice, sequencing analyses revealed a significantly lower incidence of somatic mutations in Trp53 gene in the colonic mucosa of IL-10(-/-)AID(-/-) than IL-10(-/-)AID(+/+) mice. Colon cancers spontaneously developed in the cecum in 6 of 22 (27.2%) IL-10(-/-)AID(+/+) mice. In contrast, none of the IL-10(-/-)AID(-/-) mice developed cancers except only one case of neoplasia in the distal colon. These findings suggest that the proinflammatory cytokine-induced aberrant production of AID links colonic inflammation to an enhanced genetic susceptibility to oncogenic mutagenesis. Targeting AID could be a novel strategy to prevent colitis-associated colon carcinogenesis irrespective of ongoing colonic inflammation.


Subject(s)
Colitis/enzymology , Colonic Neoplasms/enzymology , Cytidine Deaminase/metabolism , Animals , Cecum/metabolism , Colitis/complications , Colonic Neoplasms/genetics , Cytidine Deaminase/genetics , Interleukin-10/genetics , Mice , Tumor Necrosis Factor-alpha/genetics , Tumor Suppressor Protein p53/genetics
3.
Auton Autacoid Pharmacol ; 31(3-4): 64-71, 2011.
Article in English | MEDLINE | ID: mdl-21951586

ABSTRACT

1 The pressor action of the α(1A)-adrenoceptor (α(1A)-AR) agonist A61603 (N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl] methanesulfonamide) and the α(1)-ARs agonist phenylephrine and their blockade by selective α(1)-ARs antagonists in the isolated mesenteric vascular bed of wild-type (WT) mice and α(1D)-AR knockout (KO α(1D)-AR) mice were evaluated. 2 The apparent potency of A61603 to increase the perfusion pressure in the mesenteric vascular bed of WT and KO α(1D)-AR mice is 86 and 138 times the affinity of phenylephrine, respectively. 3 A61603 also enhanced the perfusion pressure by ≈1.7 fold in the mesenteric vascular bed of WT mice compared with KO α(1D)-AR mice. 4 Because of its high affinity, low concentrations of the α(1A)-AR selective antagonist RS100329 (5-methyl-3-[3-[4-[2-(2,2,2,-trifluoroethoxy) phenyl]-1-piperazinyl] propyl]-2,4-(1H)-pyrimidinedione) shifted the agonist concentration-response curves to the right in the mesenteric vascular bed of WT and KO α(1D)-AR mice. 5 The α(1D)-AR selective antagonist BMY7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5] decane-7,9-dione) did not modify the A61603 or the phenylephrine-induced pressor effect. 6 The α(1B/D)-ARs alkylating antagonist chloroethylclonidine (CEC) shifted the agonist concentration-response curves to the right and decreased the maximum phenylephrine-induced vascular contraction in KO α(1D)-AR mice when compared to WT mice; however, CEC only slightly modified the contraction induced by A61603. 7 The results indicate that the isolated mesenteric vascular bed of WT and KO α(1D)-AR mice expresses α(1A)-AR, that the pressor action of α(1A)-AR is up-regulated for α(1D)-AR in WT mice and suggest an important role of α(1B)-AR in the vascular pressure evoked by phenylephrine in KO α(1D)-AR mice.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Receptors, Adrenergic, alpha-1/physiology , Splanchnic Circulation/physiology , Vasoconstriction/physiology , Animals , Clonidine/analogs & derivatives , Clonidine/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Imidazoles/antagonists & inhibitors , Imidazoles/pharmacology , In Vitro Techniques , Male , Mice , Mice, Knockout , Phenylephrine/antagonists & inhibitors , Phenylephrine/pharmacology , Piperazines/pharmacology , Receptors, Adrenergic, alpha-1/genetics , Splanchnic Circulation/drug effects , Tetrahydronaphthalenes/antagonists & inhibitors , Tetrahydronaphthalenes/pharmacology , Thymine/pharmacology , Vasoconstriction/drug effects
4.
Auton Autacoid Pharmacol ; 31(3-4): 57-63, 2011.
Article in English | MEDLINE | ID: mdl-21951585

ABSTRACT

1 The effect of angiotensin II (Ang II) on α(1A)-, α(1B)-, and a(1D)-adrenoceptors (α(1)-AR) expression was analyzed in aorta smooth muscle cells obtained from wild-type (WT) and knock out of α(1D)-AR (α(1D)-AR KO) mice. 2 The relative abundance of mRNA for the three α(1)-ARs was determined in WT and α(1D)-AR KO aortic smooth muscle cells. There were no significant differences between WT and α(1D)-AR KO cells. 3 As early as 1 h Ang II increased α(1B)-AR mRNA in WT cells ≈ 2 fold compared with control; in contrast, in α(1D)-AR KO cells the α(1B)-AR transcript was ≈ 50% of control. 4 Western blot assays showed that Ang II incremented protein content for α(1A)-AR, 86% and 107% in WT and α(1D)-AR KO cells, respectively. 5 Protein for α(1B)- and α(1D)-ARs did not change significantly with Ang II in both WT and a(1D)-AR KO cells. 6 The effect of Ang II on α(1B)-AR mRNA seems to be influenced by the absence of α(1D)-AR in aortic smooth muscle cells, which might be important to understand the interactions among α(1)-ARs.


Subject(s)
Angiotensin II/physiology , Aorta/metabolism , Gene Expression Regulation/drug effects , Myocytes, Smooth Muscle/metabolism , Receptors, Adrenergic, alpha-1/biosynthesis , Receptors, Adrenergic, alpha-1/physiology , Angiotensin II/pharmacology , Animals , Aorta/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocytes, Smooth Muscle/drug effects , Primary Cell Culture , Receptors, Adrenergic, alpha-1/genetics
5.
Auton Autacoid Pharmacol ; 28(2-3): 81-5, 2008.
Article in English | MEDLINE | ID: mdl-18598289

ABSTRACT

1 It has been demonstrated that nerve-evoked contractions of the rat vas deferens involve alpha(1D)-adrenoceptors. Definitive evidence for a similar alpha(1D)-adrenoceptor-mediated response in mouse vas deferens has been more difficult to obtain. In this study, we have used alpha(1D)-adrenoceptor knockout (alpha(1D)-KO) mice to aid in the pharmacological characterization. 2 Mouse whole vas deferens was stimulated with a single pulse every 5 min. Once a stable response had been obtained, vehicle or antagonist was administered cumulatively at 5-min intervals and a response to stimulation obtained 5 min later. Cumulative concentration-response curves were also obtained for noradrenaline. 3 In vas deferens from alpha(1D)-KO mice, the contractile response to low concentrations of noradrenaline and the contractile response to a single stimulus were significantly reduced as compared to wild type (WT). 4 The alpha(1D)-adrenoceptor selective antagonist, BMY 7378, produced a concentration-dependent inhibition of single pulse-evoked contractions of vas deferens from WT and alpha(1D)-KO mice. BMY 7378 was significantly less potent in inhibiting stimulation-evoked contractions in vas deferens from alpha(1D)-KO mice. 5 It is concluded that alpha(1D)-adrenoceptors mediate a component of nerve- and agonist-evoked contractions of the vas deferens of WT mice.


Subject(s)
Muscle Contraction/physiology , Receptors, Adrenergic, alpha-1/physiology , Vas Deferens/physiology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Cocaine/pharmacology , Electric Stimulation , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Norepinephrine/pharmacology , Piperazines/pharmacology , Receptors, Adrenergic, alpha-1/genetics , Vas Deferens/drug effects , Vas Deferens/innervation , Vasoconstrictor Agents/pharmacology
6.
Br J Pharmacol ; 152(3): 332-40, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17603545

ABSTRACT

BACKGROUND AND PURPOSE: Alpha(1)-adrenoceptor antagonists are extensively used in the treatment of hypertension and lower urinary tract symptoms associated with benign prostatic hyperplasia. Among the side effects, ejaculatory dysfunction occurs more frequently with drugs that are relatively selective for alpha(1A)-adrenoceptors compared with other drugs of this class. This suggests that alpha(1A)-adrenoceptors may contribute to ejaculation. However, this has not been studied at the molecular level. EXPERIMENTAL APPROACH: The physiological contribution of each alpha(1)-adrenoceptor subtype was characterized using alpha(1)-adrenoceptor subtype-selective knockout (KO) mice (alpha(1A)-, alpha(1B)- and alpha(1D)-AR KO mice) since the subtype-specific drugs available are only moderately selective. We analysed the role of alpha(1)-adrenoceptors in the blood pressure and vascular response as well as ejaculation by determining these variables in alpha(1)-adrenoceptor subtype-selective KO mice and in mice with all their alpha(1)-adrenoceptor subtypes deleted (alpha(1)-AR triple-KO mice). KEY RESULTS: The pregnancy rate was reduced by 50% in alpha(1A)-adrenoceptor KO mice, and this reduction was dramatically enhanced in alpha(1)-adrenoceptor triple-KO mice. Contractile tension of the vas deferens in response to noradrenaline was markedly decreased in alpha(1A)-adrenoceptor KO mice, and this contraction was completely abolished in alpha(1)-adrenoceptor triple-KO mice. This attenuation of contractility was also observed in the electrically stimulated vas deferens. CONCLUSIONS AND IMPLICATIONS: These results demonstrate that alpha(1)-adrenoceptors, particularly alpha(1A)-adrenoceptors, are required for normal contractility of the vas deferens and consequent sperm ejaculation as well as having a function in fertility.


Subject(s)
Ejaculation/physiology , Receptors, Adrenergic, alpha-1/metabolism , Adrenergic alpha-Antagonists/adverse effects , Animals , Blood Pressure/physiology , Ejaculation/drug effects , Electric Stimulation , Female , Fertility/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle Contraction/physiology , Pregnancy , Receptors, Adrenergic, alpha-1/genetics , Semen/physiology , Vas Deferens/physiology
7.
Br J Cancer ; 97(2): 260-6, 2007 Jul 16.
Article in English | MEDLINE | ID: mdl-17579624

ABSTRACT

The purpose of this study was to investigate the accumulation of genetic alterations during metachronous and/or synchronous development of multifocal low-grade superficial urothelial tumours in the same patient, by using array-based comparative genomic hybridisation (array-CGH) and FGFR mutation analysis. We analysed 24 tumours (pTa-1 G1-2) from five patients. We had previously identified a clonal relationship among the tumours of each patient by microsatellite analysis. This time, unsupervised hierarchical cluster analysis revealed that the tumours from each patient were clustered together independently of the tumours from the other patients. All of the tumours from a single patient showed a set of 2-7 identical regional or whole-arm chromosomal changes. In addition, several individual alterations were also found. Cladistic diagrams revealed that the accumulation of genetic alterations could not be explained by a linear model, and the existence of a hypothetical precursor cell was assumed in four patients. In some cases, FGFR mutation seemed to occur later during multifocal tumour development. Taken together, these findings suggest that low-grade superficial urothelial tumours accumulate minor genetic alterations during multifocal development, although these tumours are genetically stable.


Subject(s)
Mutagenesis , Receptor, Fibroblast Growth Factor, Type 3/genetics , Urologic Neoplasms/genetics , Urothelium , Chromosomes, Human/genetics , DNA Mutational Analysis , Disease Progression , Humans , Oligonucleotide Array Sequence Analysis , Urologic Neoplasms/pathology , Urothelium/metabolism , Urothelium/pathology
8.
Auton Neurosci ; 136(1-2): 58-62, 2007 Oct 30.
Article in English | MEDLINE | ID: mdl-17512263

ABSTRACT

In an attempt to determine whether there is a specific vasopressin receptor (V(1b)) subtype involved in the regulation of body water balance and temperature, vasopressin V(1b) receptor knockout mice were used. Daily drinking behavior and renal excretory function were examined in V(1b)-deficient (V(1b)(-/-)) and control (V(1b)(+/+)) mice under the basal and stress-induced condition. In addition, body temperature and locomotor activity were measured with a biotelemetry system. The baseline daily water intake and urine volume were larger in V(1b)(-/-) mice than in V(1b)(+/+) mice. V(1b)(-/-) mice (V(1b)(-/-)) had significantly higher locomotor activity than wild-type, whereas the body temperature and oxygen consumption were lower in V(1b)(-/-) than in the V(1b)(+/+) mice. Next, the V(1b)(-/-) and V(1b)(+/+) mice were subjected to water deprivation for 48 hr. Under this condition, their body temperature decreased with the time course, which was significantly larger for V(1b)(-/-) than for V(1b)(+/+) mice. Central vasopressin has been reported to elicit drinking behavior and antipyretic action, and the V(1b) receptor has been reported to be located in the kidney. Thus, the findings suggest that the V(1b) receptor may be, at least in part, involved in body water balance and body temperature regulation.


Subject(s)
Body Temperature Regulation/genetics , Body Water/physiology , Homeostasis/genetics , Kidney/physiology , Receptors, Vasopressin/genetics , Stress, Psychological/metabolism , Vasopressins/metabolism , Animals , Basal Metabolism/physiology , Blood Pressure/physiology , Drinking/genetics , Male , Mice , Mice, Knockout , Motor Activity/genetics , Oxygen Consumption/physiology , Receptor, Serotonin, 5-HT1B , Time Factors , Urine/physiology , Water Deprivation/physiology , Water-Electrolyte Balance
10.
Diabetes Obes Metab ; 8(3): 311-21, 2006 May.
Article in English | MEDLINE | ID: mdl-16634991

ABSTRACT

AIM: Effect of running exercise on fibre-type distributions of the slow soleus and fast plantaris muscles was investigated in male Otsuka Long-Evans Tokushima fatty rats (OLETF) as an animal model of spontaneous type 2 diabetes mellitus. METHODS: Five-week-old OLETF rats were allowed to exercise voluntarily in running wheels for 32 days and the data were compared with those of age-matched non-exercised OLETF and non-diabetic Long-Evans Tokushima Otsuka rats (LETO). RESULTS: In the soleus muscle, a higher percentage of type I fibres was observed in non-exercised OLETF rats compared with LETO rats, and there were no type IIA fibres in non-exercised OLETF rats. In the plantaris muscle, a higher percentage of type IIB fibres and a lower percentage of type I and type IIA fibres were observed in non-exercised OLETF rats compared with LETO rats. In contrast, there were no differences in the fibre-type distribution of soleus and plantaris muscles between exercised OLETF and LETO rats. The body weight and type I fibre percentage of the soleus muscle were related to the running distance in exercised OLETF rats. White adipose tissue weight, HbA(1c) and blood insulin and glucose concentrations were lower in exercised OLETF rats than in non-exercised OLETF rats, irrespective of the running distance. There was a difference in the gene-expression pattern of the soleus muscle among LETO rats, non-exercised OLETF and exercised OLETF rats. CONCLUSION: Running exercise can inhibit diabetes-associated type shifting of fibres, which is more apparent with postnatal growth, in skeletal muscles of diabetic OLETF rats, as a result of mRNA expression change in muscle.


Subject(s)
Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 2/pathology , Motor Activity , Muscle, Skeletal/pathology , Adipose Tissue/pathology , Animals , Blood Glucose/metabolism , Body Weight , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Eating , Glycated Hemoglobin/metabolism , Insulin/blood , Male , Muscle Fibers, Skeletal/enzymology , Muscle Fibers, Skeletal/pathology , Muscle, Skeletal/enzymology , Organ Size , Rats , Rats, Inbred OLETF , Succinate Dehydrogenase/metabolism
11.
Auton Autacoid Pharmacol ; 25(4): 179-83, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16176450

ABSTRACT

1 We have characterized the alpha(1)-adrenoceptor subtypes present in isolated aorta of the alpha(1D)-adrenoceptor knockout (KO) mice, by chloroethylclonidine (CEC)-induced alkylation and their protection by selective alpha(1)-adrenoceptor antagonists. 2 The alpha(1D)-adrenoceptor is involved in the contractile response to noradrenaline in wild type (WT) mouse aorta. 3 In WT mice 5-methylurapidil (5-MU, an alpha(1A)-adrenoceptor antagonist) or BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-8-azaspiro[4.5] decane-7,9 dione, a selective alpha(1D)-adrenoceptor antagonist), protected the receptors from CEC-induced (alpha(1B/D)-adrenoceptor) alkylation, the combination of both antagonists resulted in complete protection, while AH11110A (1-[biphenyl-2-yloxy]-4-imino-4-piperidin-1-yl-butan-2-ol, an alpha(1B)-adrenoceptor antagonist) did not protect. 4 In aorta of KO mice there was a 19-fold rightward shift in noradrenaline effective concentration (EC(50)) compared with WT; while 5-MU alone or in combination with AH11110A protected alpha(1)-adrenoceptors to the same extent. 5 The data indicate that alpha(1A)-adrenoceptors mediate contraction and suggest their role in maintaining homeostasis in the alpha(1D)-adrenoceptors KO mice.


Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Aorta/metabolism , Clonidine/analogs & derivatives , Receptors, Adrenergic, alpha-1/physiology , Adrenergic alpha-1 Receptor Antagonists , Animals , Aorta/drug effects , Clonidine/antagonists & inhibitors , Clonidine/pharmacology , Dose-Response Relationship, Drug , Imines/pharmacology , In Vitro Techniques , Mice , Mice, Knockout , Norepinephrine , Piperazines/pharmacology , Piperidines/pharmacology , Receptors, Adrenergic, alpha-1/genetics , Vasoconstriction/drug effects , Vasoconstrictor Agents
13.
Clin Exp Immunol ; 131(3): 436-45, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12605696

ABSTRACT

Investigation of differentially expressed genes in eosinophils of patients with allergic diseases such as atopic dermatitis (AD) will provide important information for elucidating possible mechanisms of pathology. To identify novel genes that are expressed in AD, we compared gene expression in samples of peripheral blood eosinophils from AD patients and healthy volunteers. RNA was extracted from peripheral blood eosinophils. The expression of various genes, such as those for cytokine receptors, eosinophil activation marker, platelet activating factor (PAF) receptor, eosinophil-specific granular proteins and apoptosis-related genes, was confirmed using real-time reverse transcription-polymerase chain reaction (RT-PCR). Peripheral blood eosinophils of healthy volunteers were also isolated and stimulated for introduction of various cytokines. RNA was extracted and gene expression was monitored. Several genes, such as those for cytokine receptors (granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha and beta chain and interleukin (IL)-3 receptor alpha chain), CD44 and PAF receptor were expressed at significantly higher levels in AD patients than in healthy volunteers. In addition, the anti-apoptotic genes, bcl-2 and bcl-xL, were expressed at increased levels in AD patients. No single gene expression correlated with clinical markers, such as eosinophil count or IgE levels. Expression of GM-CSF receptor beta chain and IL-3 receptor alpha chain in isolated blood eosinophils of healthy volunteers was stimulated by IL-5, IL-4, interferon (IFN)-gamma and GM-CSF. Expression of bcl-2 and bcl-xL was also increased after stimulation with IL-5, IL-4 or IFN-gamma. The in vitro enhancement of cytokine-stimulated gene expression correlated well with the enhancement observed in clinical samples of eosinophils, suggesting that cytokines may affect gene expression in vivo in eosinophils of patients with AD.


Subject(s)
Cytokines/immunology , Dermatitis, Atopic/immunology , Eosinophils/immunology , Receptors, G-Protein-Coupled , Receptors, Immunologic/biosynthesis , Adolescent , Adult , Cells, Cultured , Child , Child, Preschool , Dose-Response Relationship, Immunologic , Female , Gene Expression/immunology , Humans , Hyaluronan Receptors/biosynthesis , Hyaluronan Receptors/genetics , Infant , Infant, Newborn , Male , Middle Aged , Multivariate Analysis , Platelet Membrane Glycoproteins/biosynthesis , Platelet Membrane Glycoproteins/genetics , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/genetics , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Receptors, Immunologic/genetics , Receptors, Interleukin-3/biosynthesis , Receptors, Interleukin-3/genetics , Reverse Transcriptase Polymerase Chain Reaction , Severity of Illness Index
14.
Biochem Biophys Res Commun ; 288(5): 1087-94, 2001 Nov 16.
Article in English | MEDLINE | ID: mdl-11700022

ABSTRACT

G-protein-coupled receptors (GPCRs) typically activate c-Jun N-terminal kinase (JNK) through the G protein betagamma subunit (Gbetagamma), in a manner dependent on Rho family small GTPases, in mammalian cells. Here we show that JNK activation by the prototypic Gq-coupled alpha1B-adrenergic receptor is mediated by the alpha subunit of Gq (Galphaq), not by Gbetagamma, using a transient transfection system in human embryonic kidney cells. JNK activation by the alpha1B-adrenergic receptor/Galphaq was selectively mediated by mitogen-activated protein kinase kinase 4 (MKK4), but not MKK7. Also, MKK4 activation by the alpha1B-adrenergic receptor/Galphaq required c-Src and Rho family small GTPases. Furthermore, activation of the alpha1B-adrenergic receptor stimulated JNK activity through Src family tyrosine kinases and Rho family small GTPases in hamster smooth muscle cells that natively express the alpha1B-adrenergic receptor. Together, these results suggest that the alpha1B-adrenergic receptor/Galphaq may up-regulate JNK activity through a MKK4 pathway dependent on c-Src and Rho family small GTPases in mammalian cells.


Subject(s)
GTP-Binding Protein beta Subunits , GTP-Binding Protein gamma Subunits , Heterotrimeric GTP-Binding Proteins/physiology , MAP Kinase Kinase 4 , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Animals , Cell Line , Cricetinae , GTP-Binding Protein alpha Subunits, Gq-G11 , Heterotrimeric GTP-Binding Proteins/genetics , Humans , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 7 , Mitogen-Activated Protein Kinases/genetics , Proto-Oncogene Proteins pp60(c-src)/physiology , Receptors, Adrenergic, alpha-1/genetics , Receptors, Adrenergic, alpha-1/metabolism , Transfection , rho GTP-Binding Proteins/physiology
15.
Biochem Biophys Res Commun ; 288(4): 747-51, 2001 Nov 09.
Article in English | MEDLINE | ID: mdl-11688970

ABSTRACT

Pulmonary fibrosis is a progressive disorder whose molecular pathology is poorly understood. Here we developed an in-house cDNA microarray ("lung chip") originating from a lung-normalized cDNA library. By using this lung chip, we analyzed global gene expression in a murine model of bleomycin-induced fibrosis and selected 82 genes that differed by more than twofold intensity in at least one pairwise comparison with controls. Cluster analysis of these selected genes showed that the expression of genes associated with inflammation reached maximum levels at 5 days after bleomycin administration, while genes involved in the development of fibrosis increased gradually up to 14 days after bleomycin treatment. These changes in gene expression signature were well correlated with observed histopathological changes. The results show that microarray analysis of animal disease models is a powerful approach to understanding the gene expression programs that underlie these disorders.


Subject(s)
Bleomycin/pharmacology , Gene Expression Profiling , Lung/drug effects , Lung/metabolism , Oligonucleotide Array Sequence Analysis , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/genetics , Animals , Cloning, Molecular , Cluster Analysis , Disease Models, Animal , Female , Gene Expression , Inflammation/chemically induced , Inflammation/enzymology , Inflammation/genetics , Inflammation/pathology , Mice , Mice, Inbred C57BL , Pulmonary Fibrosis/enzymology , Pulmonary Fibrosis/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Time Factors
16.
Biochem Biophys Res Commun ; 289(2): 457-62, 2001 Nov 30.
Article in English | MEDLINE | ID: mdl-11716495

ABSTRACT

To measure pH in defined intracellular microdomains of living cells, we developed ratiometric indicators based on fusing in tandem two green fluorescent protein (GFP) variants having different pH sensitivities. The indicators function in a single-excitation/dual-emission mode involving fluorescence resonance energy transfer, as well as in a dual-excitation/single-emission mode. The fluorescence ratio from GFpH and YFpH showed pH dependency and pK(a) values were 6.1 and 6.8, respectively. Using these indicators expressed in cultured cells, we measured and visualized pH changes in the cytosol and nucleus. Furthermore, by tethering the indicator to a membrane protein (the alpha(1B) adrenergic receptor), we visualized the pH in the vicinity of the protein during internalization caused by endocytosis after agonist stimulation. These novel probes will serve as a useful tool for monitoring pH in the defined organelle and in the microenvironment of a target protein, to analyze cellular function.


Subject(s)
Chemistry, Physical/methods , Luminescent Proteins/metabolism , Animals , CHO Cells , COS Cells , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cricetinae , Cytosol/metabolism , Green Fluorescent Proteins , Hydrogen-Ion Concentration , Models, Chemical , Plasmids/metabolism , Protein Structure, Tertiary , Protein Transport , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Spectrophotometry
17.
Nihon Yakurigaku Zasshi ; 118(3): 170-6, 2001 Sep.
Article in Japanese | MEDLINE | ID: mdl-11577457

ABSTRACT

Real advances in biotechnology made it possible to complete human whole genome sequencing within a short duration. Although the genome includes a huge amount of information about biological functions and the interest is now directed to the study using genomic information, the genomic strategy is not clearly understood. The following 4 studies were therefore presented and discussed about the strategy after the completion of the genomic sequence in the 74th Annual Meeting of Japanese Pharmacological Society: 1) Asthma and atopic dermatitis: models for genetic and genomic investigations of complex genetic diseases, by W.C.O. Cookson (University of Oxford, Asthma Genetics Group, Wellcome Trust Centre for Human Genetics); 2) Molecular classification by global gene expression profiling: application on oncogenomic research, by H. Aburatani (Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo); 3) Functional genomic search of disease-related genes using microarrays with normalized rat cDNA library, by G. Tsujimoto, et al. (Department of Molecular, Cell Pharmacology, National Children's Medical Research Center: and 4) Acute ischemic change of mRNA expression in the hippocampus by GeneChip array analysis: a starting point for post-genome strategy, by S. Asai, et al.


Subject(s)
Genome, Human , Sequence Analysis, DNA , Animals , Computational Biology , Gene Expression Profiling , Gene Library , Genomics , Genotype , Humans , Phenotype
18.
Nihon Rinsho ; 59(10): 1884-8, 2001 Oct.
Article in Japanese | MEDLINE | ID: mdl-11676126

ABSTRACT

Human Genome Project (information and technology) provides insights so profound that it has the ability to change the way we understand, predict, prevent, diagnose, and treat disease. Because SNPs, single nucleotide polymorphisms, are the most common type of polymorphism, they can have significant effects on both susceptibility to disease as well as drug response. In Japan, 'Millennium Project' based on SNPs has started in 2000, and National Research Centers of MHLW are performing genome-wide association study on five common diseases (dementia, cancer, diabetes mellitus, hypertension, and asthma/allergy). National Children's Hospital group studies asthma/allergy and its drug therapy. Here the overview of 'Millennium Project' and the actual research framework of National Children's Hospital group is reviewed.


Subject(s)
Asthma , Human Genome Project , Asthma/genetics , Computational Biology , Genetic Predisposition to Disease , Humans , Japan , Pharmacogenetics , Polymorphism, Single Nucleotide
19.
Jpn J Pharmacol ; 86(1): 23-31, 2001 May.
Article in English | MEDLINE | ID: mdl-11430469

ABSTRACT

The effects of bidisomide, an antiarrhythmic agent, on sodium current (I(Na)) in isolated rat ventricular myocytes were investigated using a whole cell voltage clamp method. Bidisomide blocked I(Na) with a Ki of 214 microM at a holding potential of -140 mV. The blockade of I(Na) was enhanced at a less negative holding potential of -100 mV with a Ki of 21 microM. Bidisomide shifted the steady state inactivation curve to a negative potential direction by 20 mV without a significant change in the slope factor. Bidisomide slowed the time course of recovery of I(Na) at a holding potential of -140 mV with a slow recovery phase. The time constant of recovery phase for bidisomide, disopyramide and mexiletine were 2703, 1858 and 757 ms, respectively. The development of the block of I(Na) consisted of two phases in the presence of bidisomide. The fast and slow time constants were 11 and 648 ms. Bidisomide produced a use-dependent block of I(Na) when the depolarizing pulse was repeated at 1-3 Hz. Our results indicate that bidisomide binds to rat cardiac sodium channels and that the dissociation kinetics of bidisomide from the inactivated sodium channel is slower than that of disopyramide.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Disopyramide/pharmacology , Heart/drug effects , Mexiletine/pharmacology , Myocardium/metabolism , Piperidines/pharmacology , Sodium Channels/metabolism , Animals , Electrophysiology , Heart Ventricles/drug effects , In Vitro Techniques , Kinetics , Myocardium/cytology , Patch-Clamp Techniques , Rats , Sodium Channel Blockers , Sodium Channels/drug effects
20.
Biochem Biophys Res Commun ; 284(5): 1199-203, 2001 Jun 29.
Article in English | MEDLINE | ID: mdl-11414711

ABSTRACT

Gi- and Gq-coupled G protein-coupled receptors (GPCRs) have been shown to activate c-Jun N-terminal kinase (JNK), a subfamily of mitogen-activated protein kinases (MAPKs), through Rho family small GTPases in mammalian cells. We investigated the signaling pathway linking the Gs-coupled beta2-adrenergic receptor with JNK, using smooth muscle DDT1 MF-2 cells, which natively express the beta2-adrenergic receptor. Stimulation of the beta2-adrenergic receptor activated JNK in a time-dependent manner, and a cell-permeable cyclic adenosine monophosphate analogue (8-Br-cAMP) activated JNK. The beta2-adrenergic receptor- or 8-Br-cAMP-induced activation of JNK required Rho family small GTPases. Also, the beta2-adrenergic receptor or 8-Br-cAMP induced activation of Rho family small GTPases. These results demonstrate that the beta2-adrenergic receptor/cAMP leads to JNK activation through Rho family small GTPases in DDT1 MF-2 cells. Activation of Rho family small GTPases may provide a common step in GPCR-mediated JNK activation.


Subject(s)
Cyclic AMP/physiology , Mitogen-Activated Protein Kinases/metabolism , Receptors, Adrenergic, beta-2/physiology , rho GTP-Binding Proteins/metabolism , Animals , Cells, Cultured , Cricetinae , Enzyme Activation , Humans , JNK Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...